Ownership history in M. Kraus & Co · 49 quarters on record
This page tracks every 13F SEC filing in which M. Kraus & Co reported a position in Abbott Laboratories (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 75,760 | -475 | -0.6% | 2.65% | $9.5M | $124.66 |
| 2025 Q3 | REDUCED | 76,235 | -955 | -1.2% | 2.85% | $10.2M | $132.67 |
| 2025 Q2 | REDUCED | 77,190 | -1,204 | -1.5% | 3.08% | $10.5M | $134.12 |
| 2025 Q1 | REDUCED | 78,394 | -2,432 | -3.0% | 3.16% | $10.4M | $130.21 |
| 2024 Q4 | REDUCED | 80,826 | -832 | -1.0% | 2.74% | $9.1M | $110.45 |
| 2024 Q3 | REDUCED | 81,658 | -1,618 | -1.9% | 2.73% | $9.3M | $110.80 |
| 2024 Q2 | REDUCED | 83,276 | -1,992 | -2.3% | 2.65% | $8.7M | $100.45 |
| 2024 Q1 | ADDED | 85,268 | +545 | +0.6% | 2.94% | $9.7M | $109.34 |
| 2023 Q4 | ADDED | 84,723 | +182 | +0.2% | 3.04% | $9.3M | $105.38 |
| 2023 Q3 | REDUCED | 84,541 | -160 | -0.2% | 2.91% | $8.2M | $92.21 |
As of 2025 Q4 — sorted by position size